Division of Urologic Oncology, Department of Surgical Oncology, Fox Chase Cancer Center, Temple University School of Medicine, Philadelphia, PA.
Division of Urologic Oncology, Department of Surgical Oncology, Fox Chase Cancer Center, Temple University School of Medicine, Philadelphia, PA.
Urology. 2014 Apr;83(4):843-9. doi: 10.1016/j.urology.2013.12.048.
To examine the association between high-risk patient status (age >75 years or Charlson comorbidity index count >2) and postoperative complications in patients undergoing surgical management for clinically localized renal tumors.
Patients undergoing radical nephrectomy (RN) or partial nephrectomy (PN) (2005-2012) for localized renal cell carcinoma were analyzed. Multivariate logistic regressions were used to test the association between high-risk status and postoperative complications adjusting for patient, tumor, and operative characteristics.
Of 1092 patients undergoing PN (71.9%) or RN (28.1%) for clinically localized renal tumors, 255 (23.4%) were classified as high risk, and 175 patients (16%) developed at least 1 complication (mean 1.6 ± 1.0). Of note, 22.4% and 14.1% of high- and low-risk patients developed a complication, respectively (P = .002). Comparing high- and low-risk patients, significant differences in Clavien I-II (20.4% vs 11.1%; P <.001) and medical (16.1% vs 8.1%, P <.001) complications were observed, whereas no differences were seen in Clavien III-V or surgical complications. No differences in complications were observed comparing patients treated with RN and PN, albeit high-risk patients were more likely to undergo RN (35.3% vs 25.9%, P = .04). After adjustment, the odds of incurring any complication were 1.9 times higher in high- compared with low-risk patients (odds ratio 1.9 [confidence interval 1.3-2.8]).
Regardless of surgical type, patients deemed high risk by age and comorbidity criteria were more likely to incur a postoperative complication after renal mass resection. Improved understanding of surgical risks in the elderly and infirmed will help better inform patients deciding between active surveillance and resection of renal tumors.
探讨高风险患者状态(年龄>75 岁或 Charlson 合并症指数>2)与接受手术治疗局限性肾肿瘤的患者术后并发症之间的关系。
分析了 2005 年至 2012 年间接受根治性肾切除术(RN)或部分肾切除术(PN)治疗局限性肾细胞癌的患者。使用多变量逻辑回归来测试高风险状态与术后并发症之间的关系,调整患者、肿瘤和手术特征。
在 1092 例接受 PN(71.9%)或 RN(28.1%)治疗局限性肾肿瘤的患者中,255 例(23.4%)被归类为高风险,175 例(16%)至少发生了 1 种并发症(平均 1.6±1.0)。值得注意的是,高风险和低风险患者的并发症发生率分别为 22.4%和 14.1%(P=0.002)。比较高风险和低风险患者,Clavien I-II(20.4%比 11.1%;P<.001)和医疗(16.1%比 8.1%,P<.001)并发症有显著差异,而 Clavien III-V 或手术并发症无差异。比较接受 RN 和 PN 治疗的患者,并发症无差异,尽管高风险患者更可能接受 RN(35.3%比 25.9%,P=0.04)。调整后,高风险患者发生任何并发症的几率是低风险患者的 1.9 倍(优势比 1.9[置信区间 1.3-2.8])。
无论手术类型如何,根据年龄和合并症标准判断为高风险的患者在肾肿瘤切除术后更有可能发生术后并发症。更好地了解老年和体弱患者的手术风险将有助于更好地告知患者在主动监测和肾肿瘤切除之间做出决策。